Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    June 2017
  1. AL-QATATI A, Akrong C, Stevic I, Pantel K, et al
    Plasma microRNA signature is associated with risk stratification in prostate cancer patients.
    Int J Cancer. 2017 Jun 1. doi: 10.1002/ijc.30815.
    PubMed     Text format     Abstract available


    May 2017
  2. DICKERMAN BA, Ahearn TU, Giovannucci E, Stampfer MJ, et al
    Weight change, obesity, and risk of prostate cancer progression among men with clinically localized prostate cancer.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30803.
    PubMed     Text format     Abstract available


  3. WANG Y, Freedman JA, Liu H, Moorman PG, et al
    Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30787.
    PubMed     Text format     Abstract available


    April 2017
  4. POUNIS G, Tabolacci C, Costanzo S, Cordella M, et al
    Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
    Int J Cancer. 2017 Apr 24. doi: 10.1002/ijc.30720.
    PubMed     Text format     Abstract available


  5. PEREZ-CORNAGO A, Travis RC, Appleby PN, Tsilidis KK, et al
    Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Int J Cancer. 2017 Apr 17. doi: 10.1002/ijc.30741.
    PubMed     Text format     Abstract available


    March 2017
  6. KAWADA T
    Dairy intake and prostate cancer survival.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30703.
    PubMed     Text format    


    February 2017
  7. DOWNER MK, Batista JL, Mucci LA, Stampfer MJ, et al
    Dairy intake in relation to prostate cancer survival.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30642.
    PubMed     Text format     Abstract available


    January 2017
  8. SHEN J, Li Z, Song Z, Chen J, et al
    Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30622.
    PubMed     Text format     Abstract available


  9. LUBIK AA, Nouri M, Truong S, Ghaffari M, et al
    Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
    Int J Cancer. 2017;140:358-369.
    PubMed     Text format     Abstract available


  10. HORI S, Wadhwa K, Pisupati V, Zecchini V, et al
    Loss of hSef promotes metastasis through up-regulation of EMT in prostate cancer.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30604.
    PubMed     Text format     Abstract available


    December 2016
  11. FARRIS MS, Kopciuk KA, Courneya KS, McGregor SE, et al
    Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30586.
    PubMed     Text format     Abstract available


    November 2016
  12. KUNUTSOR SK, Laukkanen JA
    Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30511.
    PubMed     Text format     Abstract available


    October 2016
  13. HAGGSTROM C, Van Hemelrijck M, Zethelius B, Robinson D, et al
    Prospective study of Type 2 Diabetes Mellitus, anti-diabetic drugs, and risk of prostate cancer.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30480.
    PubMed     Text format     Abstract available


  14. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  15. TAYLOR AE, Martin RM, Geybels MS, Stanford JL, et al
    Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30462.
    PubMed     Text format     Abstract available


  16. NAIR-SHALLIKER V, Yap S, Nunez C, Egger S, et al
    Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Cancer Lifestyle and Evaluation of Risk Study (CLEAR).
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30471.
    PubMed     Text format     Abstract available


    September 2016
  17. BRUNNER C, Davies NM, Martin RM, Eeles R, et al
    Alcohol Consumption and Prostate Cancer Incidence and Progression: A Mendelian Randomization Study.
    Int J Cancer. 2016 Sep 19. doi: 10.1002/ijc.30436.
    PubMed     Text format     Abstract available


  18. WILSON KM, Markt SC, Fang F, Nordenvall C, et al
    Snus use, smoking and survival among prostate cancer patients.
    Int J Cancer. 2016 Sep 1. doi: 10.1002/ijc.30411.
    PubMed     Text format     Abstract available


    August 2016
  19. CRAWLEY D, Garmo H, Rudman S, Stattin P, et al
    Association between duration and type of Androgen Deprivation Therapy and risk of diabetes in men with prostate cancer.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30403.
    PubMed     Text format     Abstract available


    June 2016
  20. RAMBERG H, Grytli HH, Nygard S, Wang W, et al
    PBX3 is a putative biomarker of aggressive Prostate Cancer.
    Int J Cancer. 2016 Jun 7. doi: 10.1002/ijc.30220.
    PubMed     Text format     Abstract available


    May 2016
  21. ZUCCHETTO A, Gini A, Shivappa N, Hebert JR, et al
    Dietary inflammatory index and prostate cancer survival.
    Int J Cancer. 2016 May 31. doi: 10.1002/ijc.30208.
    PubMed     Text format     Abstract available


  22. BONILLA C, Lewis SJ, Rowlands MA, Gaunt TR, et al
    Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30206.
    PubMed     Text format     Abstract available


  23. THAMILSELVAN V, Menon M, Thamilselvan S
    Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants and Akt in preclinical models: New hope for patients with prostate cancer.
    Int J Cancer. 2016 May 20. doi: 10.1002/ijc.30189.
    PubMed     Text format     Abstract available


    April 2016
  24. KENDEL F, Helbig L, Neumann K, Herden J, et al
    Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
    Int J Cancer. 2016 Apr 2. doi: 10.1002/ijc.30123.
    PubMed     Text format     Abstract available


    March 2016
  25. BURDELSKI C, Kleinhans S, Kluth M, Hube-Magg C, et al
    Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
    Int J Cancer. 2016;138:1199-206.
    PubMed     Text format     Abstract available


    February 2016
  26. LAPI F, Levi M, Simonetti M, Cancian M, et al
    Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30061.
    PubMed     Text format     Abstract available


  27. BONN SE, Sjolander A, Tillander A, Wiklund F, et al
    Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
    Int J Cancer. 2016 Feb 23. doi: 10.1002/ijc.30052.
    PubMed     Text format     Abstract available


  28. YU L, Toriseva M, Tuomala M, Seikkula H, et al
    Increased expression of fibroblast growth factor 13 (FGF13) in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
    Int J Cancer. 2016 Feb 17. doi: 10.1002/ijc.30048.
    PubMed     Text format     Abstract available


  29. RYBICKI BA, Rundle A, Kryvenko ON, Mitrache N, et al
    Methylation in Benign Prostate and Risk of Disease Progression in Men Subsequently Diagnosed with Prostate Cancer.
    Int J Cancer. 2016 Feb 10. doi: 10.1002/ijc.30038.
    PubMed     Text format     Abstract available


  30. WANG Y, Jacobs EJ, Newton CC, McCullough ML, et al
    Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study-II Nutrition Cohort.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30027.
    PubMed     Text format     Abstract available


    January 2016
  31. MURTOLA TJ, Karppa EK, Taari K, Talala K, et al
    5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30017.
    PubMed     Text format     Abstract available


  32. SUDHAN DR, Pampo C, Rice L, Siemann DW, et al
    Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29992.
    PubMed     Text format     Abstract available


    December 2015
  33. DYSHLOVOY SA, Menchinskaya ES, Venz S, Rast S, et al
    The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29977.
    PubMed     Text format     Abstract available


  34. DE CARVALHO TM, Heijnsdijk EA, de Koning HJ
    Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29976.
    PubMed     Text format     Abstract available


  35. WU K, Spiegelman D, Hou T, Albanes D, et al
    Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29973.
    PubMed     Text format     Abstract available


  36. THOMSEN FB, Folkvaljon Y, Garmo H, Robinson D, et al
    Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.
    Int J Cancer. 2015 Dec 14. doi: 10.1002/ijc.29961.
    PubMed     Text format     Abstract available


  37. LYNCH HT, Kosoko-Lasaki O, Leslie SW, Rendell M, et al
    Screening for Familial and Hereditary Prostate Cancer.
    Int J Cancer. 2015 Dec 5. doi: 10.1002/ijc.29949.
    PubMed     Text format     Abstract available


    November 2015
  38. CASTRO NAVA A, Cojoc M, Peitzsch C, Cirillo G, et al
    Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.
    Int J Cancer. 2015;137:2492-503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: